Latest Cancer treatments Stories
The FDA has approved the drug Cyramza, to be used in combination with docetexal for the treatment of non-small-cell lung cancer (NSCLC).
SAN ANTONIO, December 11, 2014 /PRNewswire/ -- - The first study in the world combining Reparixin, an oral inhibitor of CXCR1/2, with standard
--CHOP-Led Pilot Study Engineers Patients' Own Immune Cells to Hunt Down Cancer Cells in Blood-- PHILADELPHIA, Dec.
SAN FRANCISCO, Dec.
CALGARY, Dec. 4, 2014 /PRNewswire/ - Oncolytics Biotech Inc.
New campaign aims to increase awareness of immunotherapy and other gene and cell therapies. Stamford, CT (PRWEB) December 03, 2014 Alliance for Cancer
Test Tailors Cancer Treatment Plan, Improves Outcomes and Lowers Chemo Costs Franklin, Tennessee (PRWEB) December 02, 2014 DiaTech Oncology, provider
Donations will support Seattle Children's immunotherapy research trials that have spurred remission in patients who had little to no hope for recovery SEATTLE, Dec.
FOR U.S. MEDIA ONLY WOODCLIFF LAKE, N.J., Dec.
- A poem in which the author retracts something said in an earlier poem.
More Images (3 images) »